Compliance Challenges in India: Why Your Program May Not Translate: Part 2
September 9, 2016
Partner David Simon was featured in a Compliance & Ethics article, “Compliance Challenges in India: Why Your Program May Not Translate: Part 2.” The article previewed an upcoming Compliance & Ethics Institute session, where Simon is featured as a panelist, and walked through a scenario of a company’s India market strategy involving independent sales representatives allegedly taking bribes. Simon provided insight and recommended next steps from an outside counsel perspective. He said, “I would likely recommend pulling and reviewing all related government sales contracts, conducting a forensic accounting review of the payments associated with them and conducting interviews of the sales representative himself and any involved employees in an attempt to identify inappropriate payments or improper influence.”
To read more about part 1, click here.
To read more about part 1, click here.
Author(s)
Related Insights
June 6, 2025
Energy Current
House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas
On May 29, 2025, House Bill No. 3809 was signed into law by Texas Governor Greg Abbott. Born out of a crop of bills regulating renewable…
June 23, 2025
Events
Third Annual Transaction Solutions Symposium
Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.